Cipla
Indian multinational pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Cipla?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.[3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.[4][5]
Quick Facts Trade name, Formerly ...
Cipla | |
Formerly | Chemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984) |
Company type | Public |
BSE: 500087 NSE: CIPLA NSE NIFTY 50 constituent | |
ISIN | INE059A01026 |
Industry | Pharmaceuticals |
Founded | 1935 (89 years ago) (1935) |
Founder | Khwaja Abdul Hamied |
Headquarters | Mumbai, Maharashtra, India |
Area served | Worldwide |
Key people |
|
Products | |
Revenue | ₹25,455 crore (US$3.2 billion) (FY24)[1] |
₹6,233 crore (US$780 million) (FY24)[1] | |
₹4,106 crore (US$510 million) (FY24)[1] | |
Total assets | ₹32,511 crore (US$4.1 billion) (FY24)[1] |
Total equity | ₹26,706 crore (US$3.3 billion) (FY24)[1] |
Number of employees | 22,036[2] |
Subsidiaries | Invagen Pharmaceuticals |
Website | www.cipla.com |
Close